Systematic review of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei

J. Bryant, A. Clegg, M. Sidhu, H. Brodin, Pamela Lee Royle, P. Davidson

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Background: Pseudomyxoma peritonei, a rare progressive disease process within the peritoneum, is characterized by an abundance of mucinous fluid; if left untreated, the condition is fatal. The aim of this article is to assess the clinical effectiveness and costs of the Sugarbakcr procedure for pseudomyxoma peritonei.

Methods: A systematic review of the literature up to April 2004 was undertaken, with modelling of costs.

Results: Five retrospective case-series reports met the inclusion criteria. Survival after operation was approximately 95 per cent at 2 years and 60-68 per cent at 10 years, with 41-52 per cent of patients having no evidence of disease at the end of follow-up. A Monte Carlo simulation model estimated the marginal cost for one patient over a maximum of 5 years to be about pound9700 (standard deviation pound1300).

Conclusion: Evidence of the effectiveness of the Sugarbaker procedure for pseudomyxoma peritonei is limited in quantity and quality, but suggests there may be some benefit for patients. The marginal cost of the operation is about pound9700, provided that trained and experienced staff are available to perform the procedure.

Original languageEnglish
Pages (from-to)153-158
Number of pages5
JournalBritish Journal of Surgery
Volume92
DOIs
Publication statusPublished - 2005

Keywords

  • INTRAPERITONEAL CHEMOTHERAPY
  • CYTOREDUCTIVE SURGERY
  • CANCER
  • ADENOMUCINOSIS
  • CARCINOMATOSIS

Cite this

Bryant, J., Clegg, A., Sidhu, M., Brodin, H., Royle, P. L., & Davidson, P. (2005). Systematic review of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei. British Journal of Surgery, 92, 153-158. https://doi.org/10.1002/bjs.4862

Systematic review of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei. / Bryant, J.; Clegg, A.; Sidhu, M.; Brodin, H.; Royle, Pamela Lee; Davidson, P.

In: British Journal of Surgery, Vol. 92, 2005, p. 153-158.

Research output: Contribution to journalArticle

Bryant, J, Clegg, A, Sidhu, M, Brodin, H, Royle, PL & Davidson, P 2005, 'Systematic review of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei', British Journal of Surgery, vol. 92, pp. 153-158. https://doi.org/10.1002/bjs.4862
Bryant, J. ; Clegg, A. ; Sidhu, M. ; Brodin, H. ; Royle, Pamela Lee ; Davidson, P. / Systematic review of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei. In: British Journal of Surgery. 2005 ; Vol. 92. pp. 153-158.
@article{6a473b7534194a1e91bd183ac7c73850,
title = "Systematic review of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei",
abstract = "Background: Pseudomyxoma peritonei, a rare progressive disease process within the peritoneum, is characterized by an abundance of mucinous fluid; if left untreated, the condition is fatal. The aim of this article is to assess the clinical effectiveness and costs of the Sugarbakcr procedure for pseudomyxoma peritonei.Methods: A systematic review of the literature up to April 2004 was undertaken, with modelling of costs.Results: Five retrospective case-series reports met the inclusion criteria. Survival after operation was approximately 95 per cent at 2 years and 60-68 per cent at 10 years, with 41-52 per cent of patients having no evidence of disease at the end of follow-up. A Monte Carlo simulation model estimated the marginal cost for one patient over a maximum of 5 years to be about pound9700 (standard deviation pound1300).Conclusion: Evidence of the effectiveness of the Sugarbaker procedure for pseudomyxoma peritonei is limited in quantity and quality, but suggests there may be some benefit for patients. The marginal cost of the operation is about pound9700, provided that trained and experienced staff are available to perform the procedure.",
keywords = "INTRAPERITONEAL CHEMOTHERAPY, CYTOREDUCTIVE SURGERY, CANCER, ADENOMUCINOSIS, CARCINOMATOSIS",
author = "J. Bryant and A. Clegg and M. Sidhu and H. Brodin and Royle, {Pamela Lee} and P. Davidson",
year = "2005",
doi = "10.1002/bjs.4862",
language = "English",
volume = "92",
pages = "153--158",
journal = "British Journal of Surgery",
issn = "0007-1323",
publisher = "British Journal of Surgery",

}

TY - JOUR

T1 - Systematic review of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei

AU - Bryant, J.

AU - Clegg, A.

AU - Sidhu, M.

AU - Brodin, H.

AU - Royle, Pamela Lee

AU - Davidson, P.

PY - 2005

Y1 - 2005

N2 - Background: Pseudomyxoma peritonei, a rare progressive disease process within the peritoneum, is characterized by an abundance of mucinous fluid; if left untreated, the condition is fatal. The aim of this article is to assess the clinical effectiveness and costs of the Sugarbakcr procedure for pseudomyxoma peritonei.Methods: A systematic review of the literature up to April 2004 was undertaken, with modelling of costs.Results: Five retrospective case-series reports met the inclusion criteria. Survival after operation was approximately 95 per cent at 2 years and 60-68 per cent at 10 years, with 41-52 per cent of patients having no evidence of disease at the end of follow-up. A Monte Carlo simulation model estimated the marginal cost for one patient over a maximum of 5 years to be about pound9700 (standard deviation pound1300).Conclusion: Evidence of the effectiveness of the Sugarbaker procedure for pseudomyxoma peritonei is limited in quantity and quality, but suggests there may be some benefit for patients. The marginal cost of the operation is about pound9700, provided that trained and experienced staff are available to perform the procedure.

AB - Background: Pseudomyxoma peritonei, a rare progressive disease process within the peritoneum, is characterized by an abundance of mucinous fluid; if left untreated, the condition is fatal. The aim of this article is to assess the clinical effectiveness and costs of the Sugarbakcr procedure for pseudomyxoma peritonei.Methods: A systematic review of the literature up to April 2004 was undertaken, with modelling of costs.Results: Five retrospective case-series reports met the inclusion criteria. Survival after operation was approximately 95 per cent at 2 years and 60-68 per cent at 10 years, with 41-52 per cent of patients having no evidence of disease at the end of follow-up. A Monte Carlo simulation model estimated the marginal cost for one patient over a maximum of 5 years to be about pound9700 (standard deviation pound1300).Conclusion: Evidence of the effectiveness of the Sugarbaker procedure for pseudomyxoma peritonei is limited in quantity and quality, but suggests there may be some benefit for patients. The marginal cost of the operation is about pound9700, provided that trained and experienced staff are available to perform the procedure.

KW - INTRAPERITONEAL CHEMOTHERAPY

KW - CYTOREDUCTIVE SURGERY

KW - CANCER

KW - ADENOMUCINOSIS

KW - CARCINOMATOSIS

U2 - 10.1002/bjs.4862

DO - 10.1002/bjs.4862

M3 - Article

VL - 92

SP - 153

EP - 158

JO - British Journal of Surgery

JF - British Journal of Surgery

SN - 0007-1323

ER -